CME Group Inc. $CME Shares Purchased by Allworth Financial LP

Allworth Financial LP raised its position in CME Group Inc. (NASDAQ:CMEFree Report) by 18.1% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 66,675 shares of the financial services provider’s stock after purchasing an additional 10,228 shares during the period. Allworth Financial LP’s holdings in CME Group were worth $18,208,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also modified their holdings of CME. Vanguard Group Inc. boosted its stake in CME Group by 1.7% during the 4th quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider’s stock worth $9,802,366,000 after purchasing an additional 588,509 shares during the period. Ameriprise Financial Inc. increased its stake in CME Group by 2.8% in the third quarter. Ameriprise Financial Inc. now owns 4,812,914 shares of the financial services provider’s stock valued at $1,300,450,000 after purchasing an additional 130,848 shares during the period. Sanders Capital LLC acquired a new position in CME Group in the third quarter valued at $1,006,932,000. Franklin Resources Inc. raised its holdings in shares of CME Group by 0.6% in the third quarter. Franklin Resources Inc. now owns 3,381,133 shares of the financial services provider’s stock valued at $913,548,000 after buying an additional 20,213 shares during the last quarter. Finally, Invesco Ltd. raised its holdings in shares of CME Group by 23.0% in the third quarter. Invesco Ltd. now owns 2,830,323 shares of the financial services provider’s stock valued at $764,725,000 after buying an additional 528,358 shares during the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CME has been the subject of a number of recent research reports. Morgan Stanley decreased their price objective on CME Group from $362.00 to $353.00 and set an “overweight” rating for the company in a research report on Thursday, April 23rd. Barclays cut their price target on CME Group from $343.00 to $316.00 and set an “equal weight” rating for the company in a research note on Thursday, April 23rd. Weiss Ratings raised shares of CME Group from a “buy (b+)” rating to a “buy (a-)” rating in a research note on Monday, March 2nd. JPMorgan Chase & Co. upped their price objective on shares of CME Group from $266.00 to $271.00 and gave the stock an “underweight” rating in a research report on Thursday, April 16th. Finally, Argus restated a “hold” rating on shares of CME Group in a research note on Wednesday, March 4th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, CME Group has a consensus rating of “Moderate Buy” and an average price target of $305.29.

Get Our Latest Stock Analysis on CME

CME Group Trading Up 0.2%

Shares of CME opened at $297.70 on Friday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a 50 day simple moving average of $298.49 and a 200-day simple moving average of $287.99. CME Group Inc. has a 1-year low of $257.17 and a 1-year high of $329.16. The stock has a market cap of $107.87 billion, a price-to-earnings ratio of 25.40, a price-to-earnings-growth ratio of 3.59 and a beta of 0.23.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, topping the consensus estimate of $3.11 by $0.25. The company had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.CME Group’s revenue was up 14.5% compared to the same quarter last year. During the same quarter last year, the business posted $2.80 earnings per share. Equities analysts forecast that CME Group Inc. will post 12.26 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th will be issued a dividend of $1.30 per share. The ex-dividend date is Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. CME Group’s payout ratio is 44.37%.

Insider Activity

In related news, General Counsel Jonathan L. Marcus sold 3,291 shares of the firm’s stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the sale, the general counsel owned 7,192 shares in the company, valued at approximately $2,397,597.04. This trade represents a 31.39% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Martin J. Gepsman sold 300 shares of CME Group stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $305.90, for a total transaction of $91,770.00. Following the completion of the sale, the director directly owned 24,999 shares of the company’s stock, valued at $7,647,194.10. The trade was a 1.19% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 7,791 shares of company stock valued at $2,489,421 over the last 90 days. Insiders own 0.30% of the company’s stock.

Key Headlines Impacting CME Group

Here are the key news stories impacting CME Group this week:

About CME Group

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Further Reading

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.